ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER

Clinical trials for ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER explained in plain language.

Never miss a new study

Get alerted when new ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER trials appear

Sign up with your email to follow new studies for ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First patients sought for groundbreaking cancer drug trial

Disease control Recruiting now

This is a first-in-human study to test the safety and initial effectiveness of a new drug called BGB-B2033. It will be given alone or in combination with other cancer drugs to people with specific advanced or metastatic solid tumors, including certain liver, lung, stomach, and ge…

Matched conditions: ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER

Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER

Get alerted when new ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER trials appear

First patients sought for groundbreaking cancer drug trial